|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3445785 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17722080.3 |
| Date of filing the European patent application | 2017-04-18 | |
| (97) | Date of publication of the European application | 2019-02-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-22 |
| (46) | Date of publication of the claims translation | 2022-10-10 |
| (86) | Number | PCT/FI2017/050285 |
| Date | 2017-04-18 |
| (87) | Number | WO 2017/182705 |
| Date | 2017-10-26 |
| (30) | Number | Date | Country code |
| 20165335 | 2016-04-18 | FI | |
| 20165336 | 2016-04-18 | FI |
| (72) |
MAKSIMOW, Mikael , FI
JALKANEN, Markku , FI
VAINIO, Marita , FI
|
| (73) |
Faron Pharmaceuticals OY ,
Joukahaisenkatu 6, 20520 Turku,
FI
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti anti clever-1 antikūnai ir jų naudojimas |
| HUMANIZED ANTI CLEVER-1 ANTIBODIES AND THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2026-03-18 | 10 | 231.00 EUR |
| 2027-04-18 |